Clinical Trials Logo

Diabetic Neuropathy, Painful clinical trials

View clinical trials related to Diabetic Neuropathy, Painful.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06152887 Recruiting - Clinical trials for Diabetes Mellitus, Type 1

Noninvasive Cortical Neurostimulation For Diabetic Neuropathic Pain

Start date: August 1, 2023
Phase: N/A
Study type: Interventional

To investigate whether transcranial direct current stimulation can alleviate pain and sensory related disturbances in individuals with type 1 diabetes and peripheral neuropathy through neuromodulation of the CNS as compared to sham treatment.

NCT ID: NCT05623111 Recruiting - Clinical trials for Diabetic Neuropathy, Painful

Perineural Injections of Incobotulinumtoxin-A for Diabetic Neuropathic Pain of the Lower Extremities

PINBOT
Start date: August 1, 2023
Phase: Phase 2
Study type: Interventional

The goal of this clinical trial is to test perineural injections (injections around a nerve) of incobotulinumtoxin-A in participants with diabetic nerve pain of the feet and lower legs. The main questions it aims to answer are: - Is the treatment safe and effective? - Does the treatment affect participants quality of life, depression, physical activity, daily life, and sensation? Participants will be treated every 12 weeks, for a total of 24 weeks, with either incobotulinumtoxin-A or a placebo.

NCT ID: NCT05301816 Recruiting - Clinical trials for Diabetic Neuropathy, Painful

PDN Post Market, Multicenter, Prospective, Global Clinical Study

PDN-PM
Start date: July 5, 2022
Phase: N/A
Study type: Interventional

The purpose of this post-market study is to evaluate the real-world experience of Nevro's Spinal Cord Stimulation (SCS) therapy in patients with chronic, intractable leg pain due to painful diabetic neuropathy (PDN). This is a multicenter, prospective, observational global study, that will partner diabetes management teams with pain physicians to provide an interdisciplinary treatment regimen for PDN patients. Outcomes will be assessed via standardized assessments.

NCT ID: NCT01214590 Recruiting - Clinical trials for Diabetic Neuropathy, Painful

Preliminary Assessment of the Efficacy of the VascuActiveâ„¢ Device on Diabetic Peripheral Neuropathy

Start date: March 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the safety and the preliminary efficacy of treatment by the VascuActive device on peripheral diabetic neuropathy, and to correlate this effect with physiologic changes. Patients will undergo a 4-week period of home treatment by the VascuActive device, and will be monitored during this period and during a two-month follow-up period for the efficacy of the device in reducing neuropathic pain, sensation impairment and other signs and symptoms.